Literature DB >> 18326855

Antimicrobial susceptibility of periodontopathogenic bacteria.

Eva M Kulik1, Krystyna Lenkeit, Stephan Chenaux, Jürg Meyer.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the resistance profiles of Aggregatibacter (Actinobacillus) actinomycetemcomitans, Porphyromonas gingivalis and Prevotella intermedia/Prevotella nigrescens and to detect possible changes in antibiotic resistance over the time period of 1991-2005.
METHODS: A. actinomycetemcomitans (125 strains), P. gingivalis (152 strains) and P. intermedia/P. nigrescens (326 strains) isolated during the years 1991-2005 were tested for their susceptibility to amoxicillin/clavulanic acid, clindamycin, metronidazole, phenoxymethylpenicillin and tetracycline using the Etest.
RESULTS: No antibiotic resistance was detected in P. gingivalis, whereas a few isolates of P. intermedia were not susceptible to clindamycin (0.9%), phenoxymethylpenicillin (13.5%) or tetracycline (12.6%). Amoxicillin/clavulanic acid, tetracycline and metronidazole were the most effective antibiotics against A. actinomycetemcomitans with 0%, 0.8% and 20.8% non-susceptible isolates, respectively. However, 88% of the A. actinomycetemcomitans isolates were non-susceptible to phenoxymethylpenicillin and 88% to clindamycin. When strains isolated in the years 1991-94 were compared with those isolated in the years 2001-04, there was no statistically significant difference in the percentage of A. actinomycetemcomitans strains non-susceptible to clindamycin, metronidazole or phenoxymethylpenicillin, or in the percentage of P. intermedia strains non-susceptible to phenoxymethylpenicillin or tetracycline (P > 0.4 each).
CONCLUSIONS: Increasing antibiotic resistances in periodontopathogenic bacteria are not yet a problem in the Northern part of Switzerland.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18326855     DOI: 10.1093/jac/dkn079

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

Review 1.  Insights into the virulence of oral biofilms: discoveries from proteomics.

Authors:  Masae Kuboniwa; Gena D Tribble; Erik L Hendrickson; Atsuo Amano; Richard J Lamont; Murray Hackett
Journal:  Expert Rev Proteomics       Date:  2012-06       Impact factor: 3.940

2.  In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans.

Authors:  Kabilan Velliyagounder; Krishnaraj Ganeshnarayan; Senthil Kumar Velusamy; Daniel H Fine
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

3.  Genetic analysis of mobile tetQ elements in oral Prevotella species.

Authors:  Gena D Tribble; John J Garza; Victor L Yeung; Todd W Rigney; Doan-Hieu V Dao; Paulo H Rodrigues; Clay B Walker; Charles J Smith
Journal:  Anaerobe       Date:  2010-09-06       Impact factor: 3.331

4.  Development of resistance of mutans streptococci and Porphyromonas gingivalis to chlorhexidine digluconate and amine fluoride/stannous fluoride-containing mouthrinses, in vitro.

Authors:  Eva M Kulik; Tuomas Waltimo; Roland Weiger; Irene Schweizer; Krystyna Lenkeit; Elisabeth Filipuzzi-Jenny; Clemens Walter
Journal:  Clin Oral Investig       Date:  2014-12-09       Impact factor: 3.573

5.  Bimix antimicrobial scaffolds for regenerative endodontics.

Authors:  Jadesada Palasuk; Krzysztof Kamocki; Lauren Hippenmeyer; Jeffrey A Platt; Kenneth J Spolnik; Richard L Gregory; Marco C Bottino
Journal:  J Endod       Date:  2014-09-04       Impact factor: 4.171

6.  Antibacterial, anti-inflammatory, and bone-regenerative dual-drug-loaded calcium phosphate nanocarriers-in vitro and in vivo studies.

Authors:  K Madhumathi; Y Rubaiya; Mukesh Doble; R Venkateswari; T S Sampath Kumar
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

7.  One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole.

Authors:  Raluca Cosgarea; Christian Heumann; Raluca Juncar; Roxana Tristiu; Liana Lascu; Giovanni E Salvi; Nicole B Arweiler; Anton Sculean
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

8.  Antimicrobial susceptibility pattern of oral isolates of Aggregatibacter actinomycetemcomitans.

Authors:  Kishore G Bhat; Preeti Khot; Suvarna Patil; Geetha Pattar; Sanjeevini Majukar
Journal:  J Oral Maxillofac Pathol       Date:  2019 May-Aug

9.  In-Vitro Antibacterial and Anti-Inflammatory Effects of Surfactin-Loaded Nanoparticles for Periodontitis Treatment.

Authors:  Athira Johnson; Fanbin Kong; Song Miao; Sabu Thomas; Sabah Ansar; Zwe-Ling Kong
Journal:  Nanomaterials (Basel)       Date:  2021-02-01       Impact factor: 5.076

10.  Aggregatibacter actinomycetemcomitans pneumonia mimicking lung cancer in a previously healthy 12-year-old child from Saudi Arabia: a case report.

Authors:  Abdullah Al-Nafeesah
Journal:  Pan Afr Med J       Date:  2020-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.